[IBENTO][IBENTO]PMDA-ATC Pharmacovigilance Seminar 2027 applications open

Imported from official source

Announcement

Applications are now open for regulatory officials

The APEC CoE Workshop: PMDA-ATC Pharmacovigilance Seminar 2027 is a training program for regulatory officials. It will be held in person in Tokyo, Japan, from February 17 to 19, 2027.
This PMDA-ATC seminar is organized as an Asia-Pacific Economic Cooperation (APEC) Regulatory Harmonization Steering Committee (RHSC) Training Center of Excellence for Regulatory Science (CoE) workshop. It is expected to provide regulatory officials with practical insights into pharmacovigilance activities, support capacity building among regulatory authorities, and foster regulatory harmonization and cooperation across the Asia-Pacific region.

  • Development and implementation of Risk Management Plan (RMP)
  • Adverse Drug Reaction (ADR) case evaluation
  • Risk communication using labeling and risk minimization materials
  • Utilization of Real-World Data for post-marketing drug safety
  • Expert lectures delivered by APEC regulators, academia, industry representatives
  • Case studies and group discussions on ADR case evaluation, identification of safety specifications and development of risk minimization measures
  • Participant presentations and experience sharing among regulatory authorities
  • Networking opportunities with regulators from across the Asia-Pacific region
  • Practical insights into pharmacovigilance activities, including ADR case evaluation, safety specification identification, and RMP implementation
  • Strengthened regulatory capacity in pharmacovigilance and post-marketing safety management
  • Enhanced regulatory harmonization across the Asia-Pacific region through strengthened regulatory capacity, mutual learning, and collaboration among regulatory authorities
  • Working in the field of pharmacovigilance with at least three years of practical experience
  • English will be the medium at the seminar. Participants should be able to actively participate and engage in lectures and discussions in English.
  • This is an extract. The publication continues at the source.

    Source: Pharmaceuticals and Medical Devices Agency (Japan) website. Licence

    Read the original at the source: https://www.pmda.go.jp/english/symposia/0366.html

    Officially imported this from Pharmaceuticals and Medical Devices Agency (Japan)’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

    Provenance

    Organization
    Pharmaceuticals and Medical Devices Agency (Japan) — imported from official source
    Official source
    https://www.pmda.go.jp/rss_008.xml RSS
    Imported
    November 13, 2026 00:32
    Versions
    1 recorded
    Identity
    https://www.pmda.go.jp/english/symposia/0366.html

    Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.